Re-expression of estrogen receptor α using a tetracycline-regulated gene expression system induced estrogen-mediated growth inhibition of the MDA-MB-231 breast cancer cell line

Biochemistry and Cell Biology

Volumn 82, Issue 2, 2004, Pages 335-342

  Barrón González, Arturo ^a   Romero, Ivone Castro ^a  

^a INSTITUTO NACIONAL DE PERINATOLOGÍA   (Mexico)

Author keywords

Cell proliferation; Estrogen receptor ; Human breast carcinoma; MDA MB 231 cells; Tetracycline regulated gene expression system

Indexed keywords

ENZYME INHIBITION; GENES; HORMONES; PATHOLOGY; TUMORS;

ANTIESTROGENS; BREAST CANCER; ESTROGEN RECEPTORS (ER); GENE EXPRESSION;

BIOCHEMISTRY;

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; TAMOXIFEN; TETRACYCLINE;

ARTICLE; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL COUNT; CELL CYCLE S PHASE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN EXPRESSION; REGULATORY MECHANISM;

BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CLONE CELLS; DOXYCYCLINE; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUCIFERASES; RECEPTORS, PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; S PHASE; TAMOXIFEN; TRANSFECTION;

EID: 17744408271     PISSN: 08298211     EISSN: None     Source Type: Journal    
DOI: 10.1139/o03-083     Document Type: Article

References (44)

1. Alberg, A., Singh, S., May, J., and Helzlsouer, K. 2000. Epidemiology, prevention and early detection of breast cancer. Curr. Opin. Oncol. 12: 515-520.
2. Anderson, E., Clarke, R., and Howell, A. 1998. Estrogen responsiveness and control of normal human breast proliferation. J. Mammary Gland Biol. Neoplasia, 3: 23-35.
3. Ausubel, F., Brent, R., Kingston, R., Moore, D., Seidman, J., Smith, J., and Struhl, K. 1997. Current protocols in molecular biology. John Wiley and Sons Inc., Hoboken, N.J.
4. Beato, M., and Klug, J. 2000. Steroid hormone receptors: an update. Hum. Reprod. Update, 6: 225-236.
5. Breast Cancer Research Source, American Cancer Society. 2000. Available from http://www.cancer.org/docroot/stt/stt_0_2000.
6. Camacho, I., Pasapera, A., and Cerbón, M. 1996. Regulation of progesterone receptor gene expression by sex steroid hormones in the hypothalamus and the cerebral cortex of the rabbit. Neurosci. Lett. 214: 25-28.
7. Chomczinsky, P., and Sacchi, N. 1987. Single-step method for RNA isolation by acid guanidine thiocyanate-phenol-chloroform extractions. Anal. Biochem. 162: 156-159.
8. Clarke, R., Skaar, T., Baumann, K., Leonessa, F., James, M., and Lippman, J. 1994. Hormonal carcinogenesis in breast cancer; cellular and molecular studies of malignant progression. Breast Cancer Res. Treat. 31: 237-248.
9. Dickson, R., and Lippman, M. 1988. Control of human breast cancer by estrogen, growth factors and oncogenes. In Breast cancer: cellular and molecular biology. Edited by M. Lippman and R. Dickson. Kluwer, Boston, Mass. pp. 161-173.
10. Dickson, R., and Lippman, M. 1995. Growth factors in breast cancer. Endocr. Rev. 16: 559-589.
11. Druege, P., Klein-Hitpass, L., Green, S., Stack, G., Chambon, P., and Ryffel, G. 1986. Introduction of estrogen-responsiveness into mammalian cell lines. Nucleic Acids Res. 14: 9329-9337.
12. Eisen, A., and Weber, B. 1998. Recents advances in breast cancer biology. Curr. Opin. Oncol. 10: 486-491.
13. Enmark, E., and Gustafsson, J.A. 1999. Oestrogen receptors: an overview. J. Intern. Med. 246: 133-138.
14. Garcia, M., Derocq, D., Freiss, G., and Rochefort, H. 1992. Activation of estrogen receptor transfected into a receptor-negative breast cancer cell line decreases the metastatic and invasive potential of the cells. Proc. Natl. Acad. Sci. U.S.A. 89: 11538-11542.
15. González, G., Ondarza, R., Gamboa, A., Cerbón, M., and Camacho, I. 2001. Progesterone receptor isoforms expression pattern in human astrocytomas. Brain Res. Bull. 56: 43-48.
16. Gossen, M., and Bujard, H. 1992. Tight control of gene expression in mammalian cell by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89: 5547-5551.
17. Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W., and Bujard, H. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science (Washington, D.C.), 268: 1766-1769.
18. Gustafsson, J.A. 2000. An update on estrogen receptors. Semin. Perinatol. 24: 66-69.
19. Hankinson, S., and Stampfer, J. 1997. Estrogen and breast cancer. Salud Publica Mex. 39: 370-378.
20. Henderson, B., and Spencer, H. 2000. Hormonal carcinogenesis. Carcinogenesis, 21: 427-433.
21. Henderson, B., Ross, R., and Bernstein, L. 1988. Estrogens as a cause of human cancer: the Richard and Linda Rosenthal foundation award lecture. Cancer Res. 48: 246-253.
22. Hill, A., Doyle, J., McDermott, E., and O'Higgins, N. 1997. Hereditary breast cancer. Br. J. Cancer, 84: 1334-1339.
23. Jiang, S., and Jordan, C. 1992. Growth regulation of estrogen receptor negative breast cancer cells transfected with complementary DNA's for estrogen receptor. J. Natl. Cancer Inst. 84: 580-591.
24. Kelsey, L., and Berkowitz, S. 1988. Breast cancer epidemiology. Cancer Res. 48: 5615-5623.
25. Kushner, P., Hort, E., Shine, J., Baxter, J., and Greene, G. 1990. Construction of cells lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol. Endocrinol. 4: 1465-1473.
26. Lazenec, G., and Katzenellenbogen, B. 1999. Expression of human estrogen receptor using a efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells. Mol. Cell. Endocrinol. 149: 93-105.
27. Levenson, A., and Jordan, V. 1994. Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines. J. Steroid Biochem. Mol. Biol. 51: 229-239.
28. Liehr, J. 2000. Is estradiol a genotoxic mutagenic carcinogen? Endocr. Rev. 21: 40-54.
29. Lundholt, B., Madsen, M., Lykkesfeldt, A., Petersen, O., and Briand, P. 1996. Characterization of a nontumorigenic human breast epithelial cell line stably transfected with the human estrogen receptor (ER) cDNA. Mol. Cell. Endocrinol. 119: 47-59.
30. McDonnell, D., Dana, S., Hoener, P., Lieberman, B., Imhof, M., and Stein, R. 1995. Cellular mechanisms which distinguish between hormone and antihormone activated estrogen receptor. Ann. N.Y. Acad. Sci. 761: 121-137.
31. McGuirre, L. 1986. Hormone receptors in breast cancer. Vol. 5. In Cancer surveys. Edited by D. Bulbrook. Oxford University Press, Oxford, U.K. pp. 527-536.
32. Osterreich, S., Zang, P., Guler, R., Sun, X., Curran, E., Welshons, W., Osborne, K., and Lee, A. 2001. Re-expression of estrogen receptor α in estrogen receptor α-negative MCF-7 cells restore both estrogen and insulin-like growth factor-mediated siganling and growth. Cancer Res. 61: 5771-5777.
33. Parker, M. 1995. Structure and function of estrogen receptors. Vitam. Horm. 51: 267-287.
34. Pitzer, C., Schindowski, K., Power, S., Wirth, T., and Zoller, M. 1999. In vivo manipulation of interleukin-2 expression by a retroviral tetracycline (tet)-regulated system. Cancer Gene Ther. 6: 139-146.
35. Receptor Binding Techniques. 1980. Short course syllabus. Society for neuroscience, Colombus, Ohio.
36. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14: 1669-1679.
37. Russo, I., and Russo, J. 1998. Role of hormones in mammary cancer initiation and progression. J. Mammary Gland Biol. Neoplasia, 3: 49-61.
38. Wang, W., Smith, R., Burghardt, R., and Safe, H. 1997. 17β-estradiol-mediated growth inhibition of MDA-MD- 468 cells stably transfected with the estrogen receptor: cell cycle effects. Mol. Cell. Endocrinol. 133: 49-62.
39. Watts, C., and King, R. 1994. Overexpression of estrogen receptor in HTB 96 human osteosarcoma cells results in estrogen-induced growth inhibition and receptor cross-talk. J. Bone Miner. Res. 9: 1251-1258.
40. Watts, C., Parker, M., and King, R. 1989. Stable transfection of the estrogen receptor gene in a human osteosarcoma cell line. J. Steroid Biochem. 34: 483-490.
41. Wei, P., Ahn, I., Housley, R., Alam, J., and Vedeckis, V. 1998. Modulation of hormone-dependent glucocorticoid receptor function using a tetracycline-regulated expression system. J. Steroid Biochem. Mol. Biol. 64: 1-12.
42. Wettergreen, A., Hunniford, W., Crawford, M., and Adami, R. 2001. An adenoviral system for tetracycline-regulated TGF-β expression mediates a reversible cell cycle arrest. Eur. J. Oral Sci. 109: 415-421.
43. Zajchowski, D., and Sager, R. 1991. Induction of estrogen regulated genes differs in immortal and tumorigenic human mammary epithelial cells expressing a recombinant estrogen receptor. Mol. Endocrinol. 5: 1613-1623.
44. Zajchowski, D., Sager, R., and Webster, L. 1993. Estrogens inhibits the growth of estrogen receptor negative, but not estrogen receptor positive human mammary epithelial cells expressing a recombinant estrogen receptor. Cancer Res. 53: 5004-5011.